CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Otros idiomas Chongqing Zhifei Biological Products Co., Ltd.

Acciones

300122

CNE100000V20

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
34,83 ^CNY	+1,81 %		-13,98 %	-43,00 %

23/04	El beneficio de Chongqing Zhifei Biological Products en 2023 aumenta un 7%; las acciones caen un 12	MT
22/04	Chongqing Zhifei Biological Products Co., Ltd. Ltd. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12%	23/04
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Tranche Update on Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback Plan announced on February 22, 2024.	28/03
Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback announced on February 22, 2024, has closed with 6,210,253 shares, for CNY 300.01 million.	28/03
Chongqing Zhifei Biological Products Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	22/02
Chongqing Zhifei Biological Products Co., Ltd. authorizes a Buyback Plan.	22/02
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11/01
Wordt de CSI A50 de beste Chinese index?	05/01
Zhifei Biological Products to Acquire Local Biopharma Firm, Expanding Into Metabolic Disease Treatments	27/11
Chongqing Zhifei Biological Products Co., Ltd. signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd.	23/11
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Middle East Conflict Weighs on Exchange-Traded Funds, Equity Futures Pre-Bell Monday	09/10/23
GSK Signs Distribution Deal With China's Zhifei for Shingles Vaccine	09/10/23
Chongqing Zhifei Biological Enters Exclusive Distribution Deal With GSK	09/10/23
MIDDAY BRIEFING - Unternehmen und Märkte	09/10/23
Trending : GSK Signs $3 Billion Shingles Vaccine Deal in China	09/10/23
GSK schließt Abnahmevertrag für Gürtelrose-Impfstoff in China über 2,5 Mrd Pfund	09/10/23
GSK Strikes $3.06 Billion Shingles Vaccine Deal With China's Zhifei -- Update	09/10/23
European Midday Briefing : Oil Surges, Stocks Fall on Middle East Conflict	09/10/23
GSK : accord avec Zhifei en Chine pour promouvoir Shingrix	09/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Chongqing Zhifei Biological Products Co., Ltd.

Acciones

300122

CNE100000V20

Otros idiomas

Filtros